
CAS 114870-03-0
:Fondaparinux
Description:
Fondaparinux is a synthetic anticoagulant that belongs to the class of drugs known as factor Xa inhibitors. It is primarily used for the prevention and treatment of venous thromboembolism, including deep vein thrombosis and pulmonary embolism. Fondaparinux works by selectively inhibiting factor Xa, an essential component in the coagulation cascade, thereby preventing the formation of blood clots. The substance is characterized by its high bioavailability when administered subcutaneously and a long half-life, allowing for once-daily dosing. Fondaparinux is water-soluble and has a low molecular weight, which contributes to its pharmacokinetic properties. It does not require routine monitoring of anticoagulation levels, making it a convenient option for patients. Common side effects may include bleeding complications, but it is generally well-tolerated. Due to its specific mechanism of action and favorable safety profile, fondaparinux is a valuable therapeutic option in the management of thromboembolic disorders.
Formula:C31H53N3O49S8·10Na
InChI:InChI=1S/C31H53N3O49S8.10Na/c1-69-27-9(33-85(48,49)50)13(37)17(6(74-27)3-71-88(57,58)59)76-31-22(83-91(66,67)68)16(40)21(24(81-31)26(43)44)79-29-10(34-86(51,52)53)19(82-90(63,64)65)18(7(75-29)4-72-89(60,61)62)77-30-15(39)14(38)20(23(80-30)25(41)42)78-28-8(32-84(45,46)47)12(36)11(35)5(73-28)2-70-87(54,55)56;;;;;;;;;;/h5-24,27-40H,2-4H2,1H3,(H,41,42)(H,43,44)(H,45,46,47)(H,48,49,50)(H,51,52,53)(H,54,55,56)(H,57,58,59)(H,60,61,62)(H,63,64,65)(H,66,67,68);;;;;;;;;;/t5-,6-,7-,8-,9-,10-,11-,12-,13-,14-,15-,16+,17-,18-,19-,20+,21+,22-,23+,24-,27+,28-,29-,30-,31-;;;;;;;;;;/m1........../s1
InChI key:InChIKey=XNHJPDRIKNIMPQ-JASSWCPGSA-N
SMILES:O([C@H]1[C@H](OS(=O)(=O)O)[C@@H](NS(=O)(=O)O)[C@@H](O[C@@H]2[C@H](C(O)=O)O[C@@H](O[C@@H]3[C@@H](COS(=O)(=O)O)O[C@H](OC)[C@H](NS(=O)(=O)O)[C@H]3O)[C@H](OS(=O)(=O)O)[C@H]2O)O[C@@H]1COS(=O)(=O)O)[C@@H]4O[C@H](C(O)=O)[C@@H](O[C@@H]5[C@H](NS(=O)(=O)O)[C@@H](O)[C@H](O)[C@@H](COS(=O)(=O)O)O5)[C@H](O)[C@H]4O.[Na]
Synonyms:- IC 851589
- SR 90107A
- α-D-Glucopyranoside, methyl O-2-deoxy-6-O-sulfo-2-(sulfoamino)-α-D-glucopyranosyl-(1→4)-O-β-D-glucopyranuronosyl-(1→4)-O-2-deoxy-3,6-di-O-sulfo-2-(sulfoamino)-α-D-glucopyranosyl-(1→4)-O-2-O-sulfo-α-L-idopyranuronosyl-(1→4)-2-deoxy-2-(sulfoamino)-, 6-(hydrogen sulfate), sodium salt (1:10)
- Fondaparinux sodium
- α-D-Glucopyranoside, methyl O-2-deoxy-6-O-sulfo-2-(sulfoamino)-α-D-glucopyranosyl-(1→4)-O-β-D-glucopyranuronosyl-(1→4)-O-2-deoxy-3,6-di-O-sulfo-2-(sulfoamino)-α-D-glucopyranosyl-(1→4)-O-2-O-sulfo-α-L-idopyranuronosyl-(1→4)-2-deoxy-2-(sulfoamino)-, 6-(hydrogen sulfate), decasodium salt
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 13 products.
Fondaparinux Sodium System Suitability Mixture B Solution
CAS:<p>Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoi</p>Formula:C31H43N3O49S8Na10(majorcomponent)Color and Shape:Colorless LiquidMolecular weight:1726.77078Fondaparinux Sodium for Assay
CAS:<p>Heterocyclic compounds with oxygen hetero-atom(s) only nesoi</p>Formula:C31H43N3O49S8Na10Color and Shape:Clear Colorless LiquidMolecular weight:1726.77078Fondaparinux Sodium Identification
CAS:<p>Heterocyclic compounds with oxygen hetero-atom(s) only nesoi</p>Formula:C31H43N3Na10O49S8Color and Shape:White Off-White PowderMolecular weight:1726.77078Fondaparinux Sodium System Suitability Mixture A Solution
CAS:<p>Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoi</p>Formula:C31H43N3O49S8Na10(majorcomponent)Color and Shape:LiquidMolecular weight:1726.77078α-D-Glucopyranoside, methyl O-2-deoxy-6-O-sulfo-2-(sulfoamino)-α-D-glucopyranosyl-(1→4)-O-β-D-glucopyranuronosyl-(1→4)-O-2-deoxy-3,6-di-O-sulfo-2-(sulfoamino)-α-D-glucopyranosyl-(1→4)-O-2-O-sulfo-α-L-idopyranuronosyl-(1→4)-2-deoxy-2-(sulfoamino)-, 6-(hydrogen sulfate), sodium salt (1:10)
CAS:Formula:C31H43N3Na10O49S8Purity:98%Color and Shape:SolidMolecular weight:1728.0815Fondaparinux Sodium Salt
CAS:Formula:C31H43N3O49S8·10NaColor and Shape:White To Off-White SolidMolecular weight:1498.14 10*22.99Fondaparinux sodium
CAS:<p>Fondaparinux sodium (SR-90107A) is an antithrombin-dependent factor Xa inhibitor with antithrombotic activity.</p>Formula:C31H43N3Na10O49S8Purity:98% - >99.99%Color and Shape:SolidMolecular weight:1728.08Fondaparinux sodium
CAS:<p>Fondaparinux sodium is an anticoagulant, which is a synthetic pentasaccharide based on the antithrombin-binding sequence of heparin. As a meticulously engineered compound, it is derived by chemical synthesis. Its mode of action involves the selective inhibition of factor Xa, a critical enzyme in the coagulation cascade. By binding specifically to antithrombin III, it enhances the inactivation of factor Xa, thereby interrupting the pathway that leads to thrombin formation and ultimately preventing fibrin clot formation.</p>Formula:C31H43N3Na10O49S8Purity:Min. 95%Color and Shape:White Off-White PowderMolecular weight:1,728.09 g/molFondaparinux Sodium
CAS:Controlled Product<p>Applications Synthetic pentasaccharide corresponding to the anti-thrombin binding site of heparin. Anti-thrombotic.<br>References Herbert, J.M., et al.: Cardiovasc. Drug Rev., 15, 1 (1997), Turpie, A.G.G., et al.: Expert Opin. Drug Saf., 4, 707 (2005),<br></p>Formula:C31H43N3O49S8·10NaColor and Shape:White SolidMolecular weight:1728.08Fondaparinux Sodium System Suitability Mixture B (A mixture containing fondaparinux sodium and fondaparinux related compound A, B, C, D, E, F, and G) (PLANNED TO BE DISCONTINUED)
CAS:<p>Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoi</p>Formula:C31H43N3O49S8Na10Color and Shape:White PowderMolecular weight:1726.77078Fondaparinux Sodium Impurity 14
CAS:Formula:C31H42N3NaO52S9·11NaColor and Shape:White To Off-White SolidMolecular weight:1600.18 11*22.99Ref: 4Z-F-7115
Discontinued product







